Healthcare-associated infective endocarditis: An undesirable effect of healthcare universalization

Clinical Microbiology and Infection

Volumn 16, Issue 11, 2010, Pages 1683-1690

  Lomas, J M ^a   Martinez Marcos F J ^a   Plata, A ^b   Ivanova, R ^c   Galvez J ^d   Ruiz, J ^c   Reguera, J M ^b   Noureddine, M ^e   De La Torre, J ^e   De Alarcon A ^f  

^a HOSPITAL JUAN RAMÓN JIMÉNEZ   (Spain)

^b Hospital Universitario Carlos Haya   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^e HOSPITAL COSTA DEL SOL   (Spain)

^f HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Coagulase negative Staphylococcus bacteraemia; Healthcare associated; Infective endocarditis; Staphylococcus aureus bacteraemia; Vascular catheter related bacteraemia

Indexed keywords

ADULT; ARTICLE; BACTEREMIA; BACTERIAL ENDOCARDITIS; COHORT ANALYSIS; COMORBIDITY; FEMALE; HEALTH CARE UTILIZATION; HOSPITAL ADMISSION; HUMAN; INCIDENCE; INTRAVENOUS CATHETER; MAJOR CLINICAL STUDY; MALE; MEDICAL TECHNOLOGY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SEPTIC SHOCK; SPAIN; STAPHYLOCOCCUS INFECTION; SURGICAL RISK;

STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 77958591450     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2010.03043.x     Document Type: Article

References (35)

1. Giannitsioti E, Skiadas I, Antoniadou A et al. Nosocomial vs. community-acquired infective endocarditis in Greece: changing epidemiological profile and mortality risk. Clin Microbiol Infect 2007; 13: 763-769.
2. Hill EE, Vanderschueren S, Verhaegen J et al. Risk factors for infective endocarditis and outcome of patients with Staphylococcus aureus bacteraemia. Mayo Clin Proc 2007; 82: 1165-1169.
3. Hoen B, Alla F, Selton-Suty C et al. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA 2002; 288: 75-81.
4. Mouly S, Ruimy R, Launay O et al. The changing clinical aspects of infective endocarditis: descriptive review of 90 episodes in a French teaching hospital and risk factors for death. J Infect 2002; 45: 246-256.
5. Terpenning MS, Buggy BP, Kauffman CA. Hospital-acquired infective endocarditis. Arch Intern Med 1988; 148: 1601-1603.
6. Chen SC, Dwyer DE, Sorrel TC. A comparison of hospital and community-acquired infective endocarditis. Am J Cardiol 1992; 70: 1449-1452.
7. Lamas CC, Eykyn SJ. Hospital acquired native valve endocarditis: analysis of 22 cases presenting over 11 years. Heart 1998; 79: 442-447.
8. Martín-Davila P, Fortún J, Navas E et al. Nosocomial endocarditis in a tertiary hospital. An increasing trend in native valve cases. Chest 2005; 128: 772-779.
9. Fernández-Hidalgo N, Almirante B, Tornos P et al. Contemporary epidemiology and prognosis of health care-associated infective endocarditis. Clin Infect Dis 2008; 47: 1287-1297.
10. Benito N, Miró JM, De Lazzari E et al. Health care-associated native valve endocarditis: importance of non-nosocomial acquisition. Ann Intern Med 2009; 150: 586-594.
11. Li JS, Sexton DJ, Mick N et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000; 30: 633-638.
12. Ben-Ami R, Giladi M, Carmeli Y, Orni-Wasserlauf R, Siegman-Igra Y. Hospital-acquired infective endocarditis. Should the definition be broadened? Clin Infect Dis 2004; 38: 843-850.
13. O'Grady NP, Alexander M, Dellinger EP et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR 2002; 51(RR-10): 1-29.
14. Boyce JM, Potter-Bynoe G, Opal SM, Dziobek L, Medeiros AA. A common-source outbreak of Staphylococcus epidermidis infections among patients undergoing cardiac surgery. J Infect Dis 1990; 161: 493-499.
15. Van Den Broek PJ, Lampe AS, Berbée GA, Thompson J, Mouton RP. Epidemic of prosthetic valve endocarditis caused by Staphylococcus epidermidis. BMJ 1985; 291: 949-950.
16. Charlson ME, Pompei P, Ales KL, Mackenzie CR. A new method for classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383.
17. Baddour LM, Wilson WR, Bayer AS et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Disease Society of America. Circulation 2005; 111: 394-434.
18. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999; 16: 9-13.
19. Watanakunakorn C. Infective endocarditis as a result of medical progress. Am J Med 1978; 64: 917-919.
20. Pelletier LL Jr, Petersdorf RG. Infective endocarditis: a review of 125 cases from the University of Washington Hospitals, 1963-1972. Medicine 1977; 56: 287-313.
21. Pujol M, Hornero A, Saballs M, Argerich MJ, Verdaguer R, Cisnal M. Clinical epidemiology and outcomes of peripheral venous catheter-related bloodstream infections at a university-affiliated hospital. J Hosp Infect 2007; 67: 22-29.
22. Robicsek A, Beaumont JL, Peterson LR. Duration of colonization with methicillin resistant Staphylococcus aureus. Clin Infect Dis 2009; 48: 910-913.
23. Whitener C, Caputo GM, Weitekamp MR, Karchmer AW. Endocarditis due to coagulase-negative staphylococci. Infect Dis Clin North Am 1993; 7: 81-96.
24. Fernández-Guerrero ML, Verdejo C, Azofra J, De Górgolas M. Hospital-acquired infective endocarditis not associated with cardiac surgery: an emerging problem. Clin Infect Dis 1995; 20: 16-23.
25. Fowler VG, Miro JM, Hoen B et al. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 2005; 293: 3012-3021.
26. Chang FY, MacDonald BB, Peacock JE Jr et al. A prospective multicenter study of Staphylococcus aureus bacteraemia. Incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine 2003; 82: 322-332.
27. Caputo GM, Archer GL, Calderwood SB, DiNubile MJ, Karchmer AW. Native valve endocarditis due to coagulase-negative staphylococci. Am J Med 1987; 83: 619-625.
28. Aguado JM, Fernández ML, Riancho JA, Martín R, Ochoteco A. Native valve endocarditis by coagulase-negative staphylococcus. Med Clin (Barc) 1989; 93: 93-96.
29. Revilla A, San Román JA, López J, Vilacosta I, Luaces M, Fernández-Avilés F. Current profile of left-sided native valve endocarditis caused by coagulase-negative staphylococcus. Rev Esp Cardiol 2005; 58: 749-752.
30. Haro JL, Lomas JM, Plata A et al. Grupo para el Estudio de las Infecciones Cardiovasculares de la Sociedad Andaluza de Enfermedades Infecciosas. Left side native valve endocarditis by coagulase-negative staphylococci: an emerging disease. Enferm Infecc Microbiol Clin 2008; 26: 263-268.
31. McDonald JR, Olaison L, Anderson DJ et al. Enterococcal endocarditis: 107 cases from the International Collaboration on Endocarditis merged database. Am J Med 2005; 118: 759-766.
32. Fernández-Guerrero ML, Herrero L, Bellver M, Gadea I, Roblas RF, De Górgolas M. Nosocomial enterococcal endocarditis: a serious hazard for hospitalized patients with enterococcal bacteraemia. J Intern Med 2002; 252: 510-515.
33. Anderson DJ, Murdoch DR, Sexton DJ et al. Risk factors for infective endocarditis in patients with enterococcal bacteraemia: a case-control study. Infection 2004; 32: 72-77.
34. Megran DW. Enterococcal endocarditis. Clin Infect Dis 1992; 15: 63-71.
35. Mestres CA, Castro MA, Bernabeu E et al. Preoperative risk stratification in infective endocarditis. Does the EuroSCORE model work? Preliminary results. Eur J Cardiothorac Surg 2007; 32: 281-285.